Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Heart Failure

  Free Subscription


2 Am J Cardiol
3 Ann Thorac Surg
2 Cardiovasc Res
1 Chest
1 Circ Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
1 Circ Heart Fail
2 Circulation
1 Clin Cardiol
2 Eur Heart J
8 Eur J Heart Fail
2 Heart
1 Hypertension
2 Int J Cardiol
5 J Am Coll Cardiol
6 J Card Fail
1 J Mol Cell Cardiol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. LOPEZ PD, Cativo-Calderon EH, Otero D, Rashid M, et al
    The Impact of Environmental Factors on the Mortality of Patients with Chronic Heart Failure.
    Am J Cardiol. 2021 Feb 9. pii: S0002-9149(21)00090.
    PubMed         Abstract available

  2. ELKARYONI A, Sperry BW, Royce A, Walsh K, et al
    Hospitalization Rates Before and After Palliative Care Utilization for Heart Failure Patients (From a Nationwide Sample).
    Am J Cardiol. 2021 Feb 6. pii: S0002-9149(21)00109.

    Ann Thorac Surg

  3. SMAIL H, Hassan HA, Bowles C, Stock U, et al
    Impaired Baseline Renal Function May Not Influence Outcomes and Survival After Left Ventricular Assist Device Implantation.
    Ann Thorac Surg. 2021;111:511-518.
    PubMed         Abstract available

  4. GAUDINO M, Ruel M, Obadia JF, De Bonis M, et al
    Methodologic considerations on four cardiovascular interventions trials with contradictory results.
    Ann Thorac Surg. 2020 Jun 12. pii: S0003-4975(20)30911.
    PubMed         Abstract available

  5. PERSSON M, Glaser N, Franco-Cereceda A, Nilsson J, et al
    Porcine versus Bovine Bioprosthetic Aortic Valves: Long-term Clinical Results.
    Ann Thorac Surg. 2020 Jul 18. pii: S0003-4975(20)31180.
    PubMed         Abstract available

    Cardiovasc Res

  6. DE LUCIA C, Grisanti LA, Borghetti G, Piedepalumbo M, et al
    GRK5 contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
    Cardiovasc Res. 2021 Feb 9. pii: 6131786. doi: 10.1093.
    PubMed         Abstract available

  7. MELI AC, de Tombe P
    Scientists on the Spot: Myocardium and myofilaments.
    Cardiovasc Res. 2020;116:e96-e97.


  8. SHAH R, Ullah KI, Patail H, Ahmad S, et al
    A Man in His 70s With Hypotension and Increasing Abdominal Distension.
    Chest. 2020;157:e137-e139.

    Circ Cardiovasc Interv

  9. GONZALEZ FERREIRO R, Lopez Otero D, Alvarez Rodriguez L, Otero Garcia O, et al
    Prognostic Impact of Change in Nutritional Risk on Mortality and Heart Failure After Transcatheter Aortic Valve Replacement.
    Circ Cardiovasc Interv. 2021 Feb 5:CIRCINTERVENTIONS120009342.
    PubMed         Abstract available

    Circ Cardiovasc Qual Outcomes

  10. JACKEVICIUS CA, Lu L, Ghaznavi Z, Warner AL, et al
    Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
    Circ Cardiovasc Qual Outcomes. 2021 Feb 5:CIRCOUTCOMES120007230.
    PubMed         Abstract available

    Circ Heart Fail

  11. STEVENS LM, Linstead E, Hall JL, Kao DP, et al
    Association Between Coffee Intake and Incident Heart Failure Risk: A Machine Learning Analysis of the FHS, the ARIC Study, and the CHS.
    Circ Heart Fail. 2021 Feb 9:CIRCHEARTFAILURE119006799.
    PubMed         Abstract available


  12. NASSIF ME, Qintar M, Windsor SL, Jermyn R, et al
    Empagliflozin Effects on Pulmonary Artery Pressure in Patients with Heart Failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial.
    Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.052503.
    PubMed         Abstract available

  13. PACKER DL, Piccini JP, Monahan KH, Al-Khalidi HR, et al
    Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results from the CABANA Trial.
    Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.050991.
    PubMed         Abstract available

    Clin Cardiol

  14. YAZAKI M, Nabeta T, Ako J
    Response to letter to the editor entitled "Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure".
    Clin Cardiol. 2021 Feb 8. doi: 10.1002/clc.23563.

    Eur Heart J

  15. CREA F
    New guidelines on adult congenital heart disease, the fantastic four in the treatment of heart failure, and also what happened in the last year in heart failure and valvular heart disease.
    Eur Heart J. 2021;42:551-554.

  16. Corrigendum to: The Year in Cardiovascular Medicine: Heart Failure and Cardiomyopathies. The Year in Cardiovascular Medicine 2020.
    Eur Heart J. 2021 Feb 11. pii: 6132731. doi: 10.1093.

    Eur J Heart Fail

  17. MILLER WL, Sorimachi H, Grill DE, Fischer K, et al
    Contributions of Cardiac Dysfunction and Volume Status to Central Hemodynamics in Chronic Heart Failure.
    Eur J Heart Fail. 2021 Feb 9. doi: 10.1002/ejhf.2121.
    PubMed         Abstract available

  18. ROHDE LE, Vaduganathan M, Claggett BL, Polanczyk CA, et al
    Dynamic Changes in Cardiovascular and Systemic Variables Prior to Sudden Cardiac Death in Heart Failure with Reduced Ejection Fraction: a PARADIGM-HF Analysis.
    Eur J Heart Fail. 2021 Feb 9. doi: 10.1002/ejhf.2120.
    PubMed         Abstract available

  19. Addendum to the article: 'Improving risk prediction in heart failure using machine learning' [Eur J Heart Fail 2020;22:139-147].
    Eur J Heart Fail. 2020;22:2399.

  20. PAITAZOGLOU C, Bergmann MW, Ozdemir R, Pfister R, et al
    One-year results of the first-in-man study investigating the Atrial-Flow-Regulator for left-atrial shunting in symptomatic heart failure patients: the PRELIEVE study.
    Eur J Heart Fail. 2021 Feb 8. doi: 10.1002/ejhf.2119.
    PubMed         Abstract available

  21. COTTER G, Davison BA, Edwards C, Takagi K, et al
    Acute Heart Failure Treatment - A Light at The End of the Tunnel?
    Eur J Heart Fail. 2021 Feb 6. doi: 10.1002/ejhf.2116.

  22. PETRIE MC, Lee MMY, Docherty KF
    Sodium-glucose co-transporter 2 inhibitors-the first successful treatment for heart failure with preserved ejection fraction?
    Eur J Heart Fail. 2021 Jan 27. doi: 10.1002/ejhf.2108.

  23. WANG N, Cao J, Lal S
    COVID-19: getting to the heart of the matter.
    Eur J Heart Fail. 2020;22:2216-2218.

  24. VOLTERRANI M, Perrone V, Degli Esposti L
    Reply letter regarding the article "Effects of hyperkalemia and non-adherence to renin angiotensin aldosterone system inhibitors (RAASi) in patients affected by heart failure in Italy: a propensity-matched study".
    Eur J Heart Fail. 2021 Feb 8. doi: 10.1002/ejhf.2123.


  25. NISHIKAWA Y, Fukahori H, Mizuno A, Kwong JS, et al
    Cochrane corner: advance care planning for adults with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-318458. doi: 10.1136/heartjnl-2020-318458

  26. YAMAMOTO S, Yamaga T, Kawachi S, Shibuya M, et al
    Cochrane corner: Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-317888. doi: 10.1136/heartjnl-2020-317888


  27. Correction to: Clinical and Proteomic Correlates of Plasma ACE2(Angiotensin-Converting Enzyme 2) in Human Heart Failure.
    Hypertension. 2021;77:e32.

    Int J Cardiol

  28. PROUDFOOT C, Studer R, Rajput T, Jindal R, et al
    Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review.
    Int J Cardiol. 2021 Feb 2. pii: S0167-5273(21)00143.
    PubMed         Abstract available

  29. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    PubMed         Abstract available

    J Am Coll Cardiol

  30. RAO VS, Ivey-Miranda JB, Cox ZL, Riello R, et al
    Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:695-708.
    PubMed         Abstract available

  31. CUNNINGHAM JW, Claggett BL, Solomon SD, Zile MR, et al
    Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2417-2418.

    The Trials of Women in Cardiology.
    J Am Coll Cardiol. 2020;76:1931-1933.

  33. LEWIS GA, Schelbert EB, Kadler KE, Miller CA, et al
    Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2416-2417.

  34. FELKER GM, Greene SJ
    Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.
    J Am Coll Cardiol. 2021;77:709-712.

    J Card Fail

  35. GHIO S, Crimi G, Houston B, Montalto C, et al
    Non-response to acute vasodilator challenge and prognosis in heart failure with pulmonary hypertension.
    J Card Fail. 2021 Feb 5. pii: S1071-9164(21)00049.
    PubMed         Abstract available

  36. MILLER PE, van Diepen S, Metkus TS, Alviar CL, et al
    Association between Respiratory Failure and Clinical Outcomes in Patients with Acute Heart Failure: Analysis of 5 Pooled Clinical Trials.
    J Card Fail. 2021 Feb 5. pii: S1071-9164(21)00046.
    PubMed         Abstract available

  37. LALA A, Mentz RJ
    Shining a light on the vulnerable intersection of pregnancy and heart failure.
    J Card Fail. 2021;27:129.

  38. LINDLEY KJ, Walsh MN
    Pregnancy and Heart Failure: A Special Issue of the Journal of Cardiac Failure.
    J Card Fail. 2021;27:130-131.

    Heart Failure and Pregnancy: Thinking Beyond Peripartum Cardiomyopathy.
    J Card Fail. 2021;27:153-156.

  40. RICH MW
    Peripartum Cardiomyopathy and Pregnancy-Associated Heart Failure with Preserved Ejection Fraction: More Similar Than Different.
    J Card Fail. 2021;27:157-158.

    J Mol Cell Cardiol

  41. RATTKA M, Westphal S, Gahr BM, Just S, et al
    Spen deficiency interferes with Connexin 43 expression and leads to heart failure in zebrafish.
    J Mol Cell Cardiol. 2021 Feb 4. pii: S0022-2828(21)00022.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.